Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ZOM

Zomedica Corp

Apr 16 • 11:01AM ET

0.1295

Dollar change -0.0095
Percentage change -6.83	%

Healthcare • Medical Devices • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.04	Insider Own	1.59%	Shs Outstand	979.95M	Perf Week	-7.96%
Market Cap	126.90M	Forward P/E	-	EPS next Y	-	Insider Trans	2.97%	Shs Float	964.36M	Perf Month	-2.19%
Income	-34.53M	PEG	-	EPS next Q	-	Inst Own	8.88%	Short Float	6.64%	Perf Quarter	-15.41%
Sales	25.19M	P/S	5.04	EPS this Y	-	Inst Trans	-2.90%	Short Ratio	12.34	Perf Half Y	-23.19%
Book/sh	0.24	P/B	0.53	EPS next Y	-	ROA	-12.96%	Short Interest	63.99M	Perf Year	-40.35%
Cash/sh	0.09	P/C	1.40	EPS next 5Y	-	ROE	-13.61%	52W Range	0.12 - 0.25	Perf YTD	-35.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	27.70%	ROI	-14.28%	52W High	-47.14%	Beta	1.00
Dividend TTM	-	Quick Ratio	10.49	Sales past 5Y	78.21%	Gross Margin	43.75%	52W Low	7.92%	ATR (14)	0.01
Dividend Ex-Date	-	Current Ratio	11.06	EPS Y/Y TTM	-102.30%	Oper. Margin	-125.43%	RSI (14)	41.84	Volatility	3.64% 4.64%
Employees	144	Debt/Eq	0.01	Sales Y/Y TTM	33.05%	Profit Margin	-137.10%	Recom	3.00	Target Price	0.44
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	-689.66%	Payout	-	Rel Volume	1.07	Prev Close	0.14
Sales Surprise	-23.39%	EPS Surprise	-	Sales Q/Q	19.17%	Earnings	Apr 01 AMC	Avg Volume	5.18M	Price	0.13
SMA20	-6.52%	SMA50	-4.03%	SMA200	-23.33%	Trades		Volume	1,501,263	Change	-6.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-23	Initiated	Dawson James	Buy	$6

Apr-09-24 06:30AM	Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 (ACCESSWIRE)
Apr-01-24 04:05PM	Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity (ACCESSWIRE)
Mar-20-24 06:30AM	Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET (ACCESSWIRE)
Mar-14-24 06:30AM	Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform (ACCESSWIRE)
Mar-13-24 04:45PM	Zomedica Provides NYSE American Listing Update (ACCESSWIRE) +6.76%
10:30AM	Loading…
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
06:30AM	Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences (ACCESSWIRE)
Mar-07-24 06:30AM	Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs (ACCESSWIRE)
Mar-05-24 06:30AM	Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024 (ACCESSWIRE)
Feb-08-24 06:30AM	Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences (ACCESSWIRE)
Feb-06-24 04:30PM	Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) (ACCESSWIRE)
06:30AM	Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET (ACCESSWIRE)
Jan-31-24 06:30AM	Open Letter to Zomedica Shareholders from your Chief Executive Officer (ACCESSWIRE)
Jan-30-24 06:30AM	Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference (ACCESSWIRE)
Jan-25-24 04:35PM	Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split (ACCESSWIRE)
04:00PM	Loading…
Jan-17-24 04:00PM	Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split") (ACCESSWIRE)
Jan-10-24 06:30AM	Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024 (ACCESSWIRE)
Jan-04-24 06:30AM	Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel "X-Trode" Handpiece (ACCESSWIRE)
Dec-18-23 06:30AM	Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease (ACCESSWIRE) +13.53%
Dec-06-23 06:30AM	Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners (ACCESSWIRE)
Nov-28-23 06:30AM	Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference (ACCESSWIRE)
Nov-20-23 06:30AM	Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference (ACCESSWIRE)
Nov-13-23 04:20PM	Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies (ACCESSWIRE)
Nov-02-23 06:30AM	Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET (ACCESSWIRE) +6.93%
Oct-11-23 06:30AM	Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference (ACCESSWIRE)
Oct-05-23 06:30AM	Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development (ACCESSWIRE)
Sep-27-23 06:30AM	Zomedica, Inc. to Present at the LD Micro Main Event XVI (Newsfile)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-14-23 06:30AM	Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushings Disease in Horses (ACCESSWIRE)
Sep-13-23 04:30PM	Zomedica Provides Corporate Update (ACCESSWIRE)
04:30PM	Loading…
Sep-05-23 04:30PM	Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio (ACCESSWIRE)
Aug-31-23 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-10-23 04:25PM	Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity (ACCESSWIRE)
Aug-08-23 06:30AM	Zomedica to Present at Sidoti Virtual Investor Conference August 16-17 (ACCESSWIRE)
Aug-04-23 06:30AM	Zomedica to Host Second Quarter Financial Results Call on August 10 (ACCESSWIRE)
Aug-02-23 12:45PM	RedChip Launches 'Small Stocks, Big Money' Podcast (ACCESSWIRE)
Jun-09-23 07:30AM	Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services (ACCESSWIRE)
May-12-23 04:15PM	Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference (ACCESSWIRE) -6.98%
May-11-23 04:25PM	Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity (ACCESSWIRE)
May-08-23 06:30AM	Zomedica Exercises Option to Acquire Structured Monitoring Products (ACCESSWIRE)
May-02-23 06:30AM	Zomedica to Host First Quarter Financial Results Call on May 11 (ACCESSWIRE)
Apr-18-23 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Mar-31-23 09:00AM	Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Mar-17-23 06:30AM	Zomedica Appoints New Chief Financial Officer (ACCESSWIRE) -18.31%
Mar-15-23 04:45PM	Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth (ACCESSWIRE)
Mar-08-23 06:30AM	Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15 (ACCESSWIRE)
Feb-09-23 06:30AM	Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022 (ACCESSWIRE)
Feb-08-23 04:15PM	Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Jan-25-23 08:00AM	RedChip CEO Dave Gentry Invited to Join Forbes Business Council (ACCESSWIRE)
Jan-24-23 06:00AM	Zomedica to Participate in the Lytham Partners Investor Select Conference (ACCESSWIRE)
Jan-18-23 06:00AM	Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies (ACCESSWIRE) -8.52%
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference (ACCESSWIRE) +17.01%
06:00AM	Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors (ACCESSWIRE)
Jan-11-23 06:00AM	Zomedica to Present at Sidoti Virtual Investor Conference January 18-19 (ACCESSWIRE)
Dec-15-22 06:30AM	Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans (ACCESSWIRE)
Nov-14-22 04:20PM	Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities (ACCESSWIRE)
Oct-18-22 06:30AM	Zomedica to Present at LD Micro Main Event XV Conference (ACCESSWIRE)
Sep-28-22 06:30AM	Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference (ACCESSWIRE)
Sep-13-22 06:30AM	Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform (ACCESSWIRE)
Sep-12-22 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference (ACCESSWIRE)
Sep-06-22 06:30AM	Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association (ACCESSWIRE) -9.88%
Aug-23-22 06:30AM	Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors (ACCESSWIRE)
Aug-15-22 05:20PM	Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues (ACCESSWIRE)
Aug-09-22 07:00AM	Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference (Newsfile) -6.26%
Jul-18-22 06:15AM	Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health (ACCESSWIRE)
Jul-07-22 04:15PM	Zomedica Announces New Global Manufacturing & Distribution Center (ACCESSWIRE)
Jul-06-22 06:30AM	Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared (ACCESSWIRE) +13.86%
Jun-28-22 06:30AM	Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team (ACCESSWIRE)
Jun-21-22 06:30AM	Zomedica to Participate in Panel Discussion at Animal Health Investment Forum (ACCESSWIRE)
Jun-15-22 06:15AM	Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared (ACCESSWIRE) +15.24%
Jun-13-22 06:30AM	Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses (ACCESSWIRE)
Jun-08-22 06:30AM	Zomedica to Present at JMP Securities Life Sciences Conference (ACCESSWIRE)
Jun-02-22 06:30AM	Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary (ACCESSWIRE) +5.76%
May-19-22 06:30AM	Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line (ACCESSWIRE) -5.85%
May-18-22 08:00AM	Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp. (ACCESSWIRE)
May-16-22 06:30AM	Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans (ACCESSWIRE)
May-10-22 04:25PM	Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues (ACCESSWIRE)
May-04-22 06:30AM	Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship (ACCESSWIRE)
Apr-27-22 06:30AM	Zomedica to Present at H.C. Wainwright Global Investment Conference (ACCESSWIRE)
Apr-13-22 06:30AM	Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association (ACCESSWIRE)
Apr-04-22 06:52AM	Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform (ACCESSWIRE)
Mar-03-22 02:05PM	Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica? (InvestorPlace)
Mar-01-22 04:50PM	Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results (ACCESSWIRE) +11.00%
Feb-28-22 07:30AM	Zomedica Announces Participation in the Q1 Virtual Investor Summit (Newsfile)
Feb-25-22 04:20PM	Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin (ACCESSWIRE)
Feb-16-22 03:14PM	Zomedicas Shareholders Should Be Worried About the Outlook of ZOM Stock (InvestorPlace) +26.28%
Feb-15-22 06:05AM	Zomedica Appoints Adrian Lock to Lead Sales Organization (ACCESSWIRE)
Feb-09-22 06:05AM	Zomedica Announces Management Team Additions (ACCESSWIRE Test RSS)
Jan-27-22 06:00AM	Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022 (ACCESSWIRE)
Jan-18-22 05:38PM	Sargent Bickham Lagudis LLC Buys iShares Core S&P 500 ETF, Vanguard FTSE Emerging Markets ... (GuruFocus.com)
Jan-10-22 06:30AM	Zomedica CEO Provides Update to Shareholders (ACCESSWIRE)
Jan-07-22 09:58AM	Theres a Reason to Consider Buying Zomedica, and Its a Real Shocker (InvestorPlace)
Dec-15-21 09:50AM	Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference (ACCESSWIRE)
Dec-03-21 06:00AM	Zomedica Stock Looks Tempting Here, But Theres Likely More Downside (InvestorPlace) -13.16%
Nov-17-21 04:21PM	Zomedica Is Languishing Today, but Keep an Eye on This Risky Play (InvestorPlace)
Nov-12-21 04:10PM	Zomedica Announces Third Quarter 2021 Financial Results (ACCESSWIRE)
Oct-21-21 08:00AM	SPAR Group Elects Mr. Sean M. Whelan and Mr. Michael Wager to its Board of Directors (GlobeNewswire)
Oct-04-21 06:05AM	Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan (GlobeNewswire) -6.83%
Oct-01-21 06:01AM	Zomedica Acquires PulseVet (GlobeNewswire) +8.77%

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
POWERS JOHNNY D	Director	Dec 15 '23	Buy	0.17	100,000	16,500	1,950	Dec 18 09:20 AM
POWERS JOHNNY D	Director	Nov 17 '23	Buy	0.17	100,000	16,600	1,850,000	Nov 20 04:31 PM
HEATON LARRY C II	CEO	Nov 17 '23	Buy	0.17	100,000	16,600	200,000	Nov 17 04:50 PM
POWERS JOHNNY D	Director	Nov 15 '23	Buy	0.17	150,000	25,950	1,750,000	Nov 16 04:31 PM
HEATON LARRY C II	CEO	May 26 '23	Buy	0.19	100,000	19,090	100,000	May 26 03:03 PM
POWERS JOHNNY D	Director	May 25 '23	Buy	0.19	100,000	19,340	1,600,000	May 25 05:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZOM

Zomedica Corp

Upgrade your FINVIZ experience